Marchenko, A. V.Ananieva, M. M.Faustova, M. O.Loban’, G. A.Lytovchenko, I. Yu.Nikolishyn, I. A.Ilenko-Lobach, N. V.Марченко, Алла ВолодимирівнаАнаньєва, Майя МиколаївнаФаустова, Марія ОлексіївнаЛобань, Галина АндріївнаЛітовченко, Ірина ЮріївнаНіколішин, Ігор АнатолійовичІленко-Лобач, Наталія Володимирівна2021-06-082021-06-082021Epidemiological data on the detection of immunoglobulins of class IgM, IgG to SARS-Cov-2 among population of Poltava region / A. V. Marchenko, M. M. Ananieva, M. O. Faustova [et al.] // Wiadomosci Lekarskie. – 2021. – Vol. LXXIV, issue 5. – Р. 1134–1136.0043-5147https://repository.pdmu.edu.ua/handle/123456789/16084The aim: Of this study was to analyze epidemiological data on the detection of immunoglobulins of class M and G (IgM, IgG) to SARS-CoV-2 among urban and rural population of Poltava region. Materials and methods: We have analyzed the research results of 2841 patients to determine IgM and IgG levels to SARS-CoV-2. The study included the results of patients in Poltava and nearby villages of Poltava region, obtained during July – December 2020. Results: Thus, 84% of patients applied for detection of IgM in the serum of patients with the pathogen COVID-2019. We have found only 135 positive results for the detection of IgM to SARS-CoV-2, which was 5.7% of the total number of people who underwent this study from July to December 2020. Moreover, women received a positive result more often than men. The IP samples for the detection of IgM to SARS-CoV-2 in the serum of patients averaged 2.5 ± 1.04. It was found that patients went to the laboratory to detect IgG to SARS-CoV-2 with the vast majority among them were residents of Poltava. However, in this case the share of positive results was 47.7%, among which the female population outnumbered the male. Conclusions: The frequency of detection of positive results on IgM to SARS-CoV-2 is about 6%. The share of positive results on IgG to SARS-CoV-2 was 47.7%, among them 76.2% were women. The frequency of detection of IgM and IgG to SARS-CoV-2 during October-December 2020 significantly exceeds the indices in July-September of the same year.enIgGCOVID-2019frequencySARS-CoV-2IgMArticle10.36740/WLek202105116